25 XP   0   0   10

Chongqing Lummy Pharmaceutical
Buy, Hold or Sell?

Let's analyse Chongqing Lummy Pharmaceutical together

PenkeI guess you are interested in Chongqing Lummy Pharmaceutical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chongqing Lummy Pharmaceutical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chongqing Lummy Pharmaceutical

I send you an email if I find something interesting about Chongqing Lummy Pharmaceutical.

Quick analysis of Chongqing Lummy Pharmaceutical (30 sec.)










What can you expect buying and holding a share of Chongqing Lummy Pharmaceutical? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.01
Expected worth in 1 year
¥1.77
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
¥-0.19
Return On Investment
-6.7%

For what price can you sell your share?

Current Price per Share
¥2.90
Expected price per share
¥2.03 - ¥3.17
How sure are you?
50%

1. Valuation of Chongqing Lummy Pharmaceutical (5 min.)




Live pricePrice per Share (EOD)

¥2.90

Intrinsic Value Per Share

¥-1.66 - ¥2.48

Total Value Per Share

¥0.35 - ¥4.49

2. Growth of Chongqing Lummy Pharmaceutical (5 min.)




Is Chongqing Lummy Pharmaceutical growing?

Current yearPrevious yearGrowGrow %
How rich?$293m$301.7m-$8.6m-3.0%

How much money is Chongqing Lummy Pharmaceutical making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$9.4m$8.2m669.6%
Net Profit Margin-1.0%-7.8%--

How much money comes from the company's main activities?

3. Financial Health of Chongqing Lummy Pharmaceutical (5 min.)




What can you expect buying and holding a share of Chongqing Lummy Pharmaceutical? (5 min.)

Welcome investor! Chongqing Lummy Pharmaceutical's management wants to use your money to grow the business. In return you get a share of Chongqing Lummy Pharmaceutical.

What can you expect buying and holding a share of Chongqing Lummy Pharmaceutical?

First you should know what it really means to hold a share of Chongqing Lummy Pharmaceutical. And how you can make/lose money.

Speculation

The Price per Share of Chongqing Lummy Pharmaceutical is ¥2.9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chongqing Lummy Pharmaceutical.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chongqing Lummy Pharmaceutical, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.01. Based on the TTM, the Book Value Change Per Share is ¥-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chongqing Lummy Pharmaceutical.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%-0.01-0.3%-0.02-0.6%-0.01-0.2%
Usd Book Value Change Per Share-0.01-0.3%-0.01-0.3%0.00-0.1%0.010.4%0.010.4%
Usd Dividend Per Share0.000.1%0.000.1%0.000.1%0.010.2%0.010.3%
Usd Total Gains Per Share-0.01-0.2%-0.01-0.2%0.000.0%0.020.6%0.020.7%
Usd Price Per Share0.51-0.51-0.53-0.76-1.60-
Price to Earnings Ratio-440.00--440.00--58.55--126.53-625.33-
Price-to-Total Gains Ratio-77.03--77.03--414.88--68.30--76.74-
Price to Book Ratio1.85-1.85-1.84-3.39-8.44-
Price-to-Total Gains Ratio-77.03--77.03--414.88--68.30--76.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.40049
Number of shares2496
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.02
Gains per Quarter (2496 shares)-16.6543.98
Gains per Year (2496 shares)-66.59175.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
115-82-7772104166
231-164-144144208342
346-246-211216312518
462-328-278288416694
577-410-345360520870
692-492-4124326241046
7108-574-4795047281222
8123-656-5465768321398
9139-738-6136479361574
10154-820-68071910401750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%5.05.00.050.0%13.05.00.072.2%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%12.06.00.066.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%14.04.00.077.8%

Fundamentals of Chongqing Lummy Pharmaceutical

About Chongqing Lummy Pharmaceutical

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company provides antibacterial, antifungal, antiviral agent, acid-base balance nutritional, liver auxiliary, Chinese patent, base large infusion drugs; American ginseng; and drugs for the treatment of tumors, as well as digestive, immune, blood, nervous, cardiovascular, and endocrinology systems. It also offers sodium bicarbonate injection. The company was founded in 1999 and is headquartered in Chongqing, China.

Fundamental data was last updated by Penke on 2024-04-16 11:22:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Chongqing Lummy Pharmaceutical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chongqing Lummy Pharmaceutical earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -1.0% means that ¥-0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is -1.0%. The company is not making a profit/loss.
  • The TTM is -1.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM-1.0%0.0%
TTM-1.0%YOY-7.8%+6.8%
TTM-1.0%5Y-9.2%+8.2%
5Y-9.2%10Y-3.1%-6.0%
1.1.2. Return on Assets

Shows how efficient Chongqing Lummy Pharmaceutical is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • -0.3% Return on Assets means that Chongqing Lummy Pharmaceutical generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-0.3%0.0%
TTM-0.3%YOY-2.2%+1.9%
TTM-0.3%5Y-4.2%+3.9%
5Y-4.2%10Y-1.4%-2.7%
1.1.3. Return on Equity

Shows how efficient Chongqing Lummy Pharmaceutical is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • -0.4% Return on Equity means Chongqing Lummy Pharmaceutical generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.4%0.0%
TTM-0.4%YOY-3.2%+2.8%
TTM-0.4%5Y-9.2%+8.8%
5Y-9.2%10Y-3.5%-5.8%

1.2. Operating Efficiency of Chongqing Lummy Pharmaceutical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chongqing Lummy Pharmaceutical is operating .

  • Measures how much profit Chongqing Lummy Pharmaceutical makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-12.0%+12.0%
TTM-5Y-5.9%+5.9%
5Y-5.9%10Y0.6%-6.6%
1.2.2. Operating Ratio

Measures how efficient Chongqing Lummy Pharmaceutical is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are ¥1.36 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 1.357. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.357. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.357TTM1.3570.000
TTM1.357YOY1.328+0.029
TTM1.3575Y1.316+0.041
5Y1.31610Y1.295+0.021

1.3. Liquidity of Chongqing Lummy Pharmaceutical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chongqing Lummy Pharmaceutical is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.93 means the company has ¥2.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 2.928. The company is able to pay all its short-term debts. +1
  • The TTM is 2.928. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.928TTM2.9280.000
TTM2.928YOY2.489+0.438
TTM2.9285Y2.006+0.921
5Y2.00610Y1.512+0.494
1.3.2. Quick Ratio

Measures if Chongqing Lummy Pharmaceutical is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.58 means the company can pay off ¥0.58 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 0.575. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.575. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.575TTM0.5750.000
TTM0.575YOY0.473+0.102
TTM0.5755Y0.506+0.069
5Y0.50610Y0.455+0.051

1.4. Solvency of Chongqing Lummy Pharmaceutical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chongqing Lummy Pharmaceutical assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chongqing Lummy Pharmaceutical to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.27 means that Chongqing Lummy Pharmaceutical assets are financed with 26.6% credit (debt) and the remaining percentage (100% - 26.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 0.266. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.266. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.2660.000
TTM0.266YOY0.285-0.019
TTM0.2665Y0.386-0.120
5Y0.38610Y0.408-0.022
1.4.2. Debt to Equity Ratio

Measures if Chongqing Lummy Pharmaceutical is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 36.9% means that company has ¥0.37 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chongqing Lummy Pharmaceutical:

  • The MRQ is 0.369. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.369. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.369TTM0.3690.000
TTM0.369YOY0.410-0.040
TTM0.3695Y0.787-0.417
5Y0.78710Y0.796-0.009

2. Market Valuation of Chongqing Lummy Pharmaceutical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chongqing Lummy Pharmaceutical generates.

  • Above 15 is considered overpriced but always compare Chongqing Lummy Pharmaceutical to the Drug Manufacturers - General industry mean.
  • A PE ratio of -440.00 means the investor is paying ¥-440.00 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chongqing Lummy Pharmaceutical:

  • The EOD is -343.008. Based on the earnings, the company is expensive. -2
  • The MRQ is -439.996. Based on the earnings, the company is expensive. -2
  • The TTM is -439.996. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-343.008MRQ-439.996+96.988
MRQ-439.996TTM-439.9960.000
TTM-439.996YOY-58.551-381.445
TTM-439.9965Y-126.526-313.470
5Y-126.52610Y625.325-751.852
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chongqing Lummy Pharmaceutical:

  • The EOD is 137.859. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 176.840. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 176.840. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD137.859MRQ176.840-38.981
MRQ176.840TTM176.8400.000
TTM176.840YOY-364.051+540.891
TTM176.8405Y-0.993+177.833
5Y-0.99310Y-14.047+13.054
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chongqing Lummy Pharmaceutical is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.85 means the investor is paying ¥1.85 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Chongqing Lummy Pharmaceutical:

  • The EOD is 1.443. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.851. Based on the equity, the company is underpriced. +1
  • The TTM is 1.851. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.443MRQ1.851-0.408
MRQ1.851TTM1.8510.000
TTM1.851YOY1.841+0.010
TTM1.8515Y3.385-1.534
5Y3.38510Y8.437-5.052
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Chongqing Lummy Pharmaceutical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.059-0.0590%-0.026-57%0.075-179%0.094-163%
Book Value Per Share--2.0102.0100%2.069-3%1.781+13%1.632+23%
Current Ratio--2.9282.9280%2.489+18%2.006+46%1.512+94%
Debt To Asset Ratio--0.2660.2660%0.285-7%0.386-31%0.408-35%
Debt To Equity Ratio--0.3690.3690%0.410-10%0.787-53%0.796-54%
Dividend Per Share--0.0110.0110%0.017-32%0.052-79%0.061-82%
Eps---0.008-0.0080%-0.065+670%-0.125+1379%-0.044+426%
Free Cash Flow Per Share--0.0210.0210%-0.010+150%0.081-74%0.057-63%
Free Cash Flow To Equity Per Share--0.0210.0210%0.147-86%0.083-75%0.103-80%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.483--------
Intrinsic Value_10Y_min---1.665--------
Intrinsic Value_1Y_max--0.118--------
Intrinsic Value_1Y_min---0.023--------
Intrinsic Value_3Y_max--0.454--------
Intrinsic Value_3Y_min---0.195--------
Intrinsic Value_5Y_max--0.910--------
Intrinsic Value_5Y_min---0.501--------
Market Cap3062139046.400-28%3927989682.6003927989682.6000%4023021691.050-2%5792725760.206-32%12217936501.351-68%
Net Profit Margin---0.010-0.0100%-0.078+679%-0.092+822%-0.031+216%
Operating Margin----0%-0.1200%-0.0590%0.006-100%
Operating Ratio--1.3571.3570%1.328+2%1.316+3%1.295+5%
Pb Ratio1.443-28%1.8511.8510%1.841+1%3.385-45%8.437-78%
Pe Ratio-343.008+22%-439.996-439.9960%-58.551-87%-126.526-71%625.325-170%
Price Per Share2.900-28%3.7203.7200%3.810-2%5.486-32%11.571-68%
Price To Free Cash Flow Ratio137.859-28%176.840176.8400%-364.051+306%-0.993+101%-14.047+108%
Price To Total Gains Ratio-60.049+22%-77.029-77.0290%-414.883+439%-68.299-11%-76.7410%
Quick Ratio--0.5750.5750%0.473+22%0.506+14%0.455+26%
Return On Assets---0.003-0.0030%-0.022+628%-0.042+1247%-0.014+363%
Return On Equity---0.004-0.0040%-0.032+654%-0.092+2053%-0.035+705%
Total Gains Per Share---0.048-0.0480%-0.009-81%0.128-138%0.155-131%
Usd Book Value--293071119.192293071119.1920%301743529.606-3%259755130.147+13%237982373.765+23%
Usd Book Value Change Per Share---0.008-0.0080%-0.004-57%0.010-179%0.013-163%
Usd Book Value Per Share--0.2780.2780%0.286-3%0.246+13%0.225+23%
Usd Dividend Per Share--0.0020.0020%0.002-32%0.007-79%0.008-82%
Usd Eps---0.001-0.0010%-0.009+670%-0.017+1379%-0.006+426%
Usd Free Cash Flow--3067494.9243067494.9240%-1526104.265+150%11876060.195-74%7432179.642-59%
Usd Free Cash Flow Per Share--0.0030.0030%-0.001+150%0.011-74%0.008-63%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%0.020-86%0.011-75%0.014-80%
Usd Market Cap422881402.308-28%542455375.167542455375.1670%555579295.534-2%799975427.484-32%1687297030.837-68%
Usd Price Per Share0.400-28%0.5140.5140%0.526-2%0.758-32%1.598-68%
Usd Profit---1232864.062-1232864.0620%-9488729.384+670%-18232728.567+1379%-6486425.007+426%
Usd Revenue--123681347.095123681347.0950%122161433.779+1%178092221.658-31%167882754.997-26%
Usd Total Gains Per Share---0.007-0.0070%-0.001-81%0.018-138%0.021-131%
 EOD+4 -4MRQTTM+0 -0YOY+17 -175Y+16 -1810Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Chongqing Lummy Pharmaceutical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-343.008
Price to Book Ratio (EOD)Between0-11.443
Net Profit Margin (MRQ)Greater than0-0.010
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.575
Current Ratio (MRQ)Greater than12.928
Debt to Asset Ratio (MRQ)Less than10.266
Debt to Equity Ratio (MRQ)Less than10.369
Return on Equity (MRQ)Greater than0.15-0.004
Return on Assets (MRQ)Greater than0.05-0.003
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Chongqing Lummy Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.955
Ma 20Greater thanMa 502.848
Ma 50Greater thanMa 1002.868
Ma 100Greater thanMa 2003.204
OpenGreater thanClose2.870
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -169,720-173,885-343,604237,640-105,96530,717-75,24878,8423,594
Net Interest Income  -70,973-8,860-79,83361,094-18,73911,164-7,57529,61722,042



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,890,880
Total Liabilities768,714
Total Stockholder Equity2,080,652
 As reported
Total Liabilities 768,714
Total Stockholder Equity+ 2,080,652
Total Assets = 2,890,880

Assets

Total Assets2,890,880
Total Current Assets1,646,171
Long-term Assets1,244,709
Total Current Assets
Cash And Cash Equivalents 836,437
Net Receivables 323,382
Inventory 170,997
Other Current Assets 3,584
Total Current Assets  (as reported)1,646,171
Total Current Assets  (calculated)1,334,399
+/- 311,771
Long-term Assets
Property Plant Equipment 286,968
Goodwill 32,943
Intangible Assets 211,996
Long-term Assets Other 60,192
Long-term Assets  (as reported)1,244,709
Long-term Assets  (calculated)592,098
+/- 652,611

Liabilities & Shareholders' Equity

Total Current Liabilities562,272
Long-term Liabilities206,441
Total Stockholder Equity2,080,652
Total Current Liabilities
Short Long Term Debt 113,500
Accounts payable 37,902
Other Current Liabilities 2,310
Total Current Liabilities  (as reported)562,272
Total Current Liabilities  (calculated)153,712
+/- 408,561
Long-term Liabilities
Long term Debt 126,500
Capital Lease Obligations Min Short Term Debt2,527
Long-term Liabilities Other 51,762
Long-term Liabilities  (as reported)206,441
Long-term Liabilities  (calculated)180,788
+/- 25,653
Total Stockholder Equity
Total Stockholder Equity (as reported)2,080,652
Total Stockholder Equity (calculated)0
+/- 2,080,652
Other
Capital Stock1,055,911
Common Stock Shares Outstanding 1,055,911
Net Invested Capital 2,320,652
Net Working Capital 1,083,898
Property Plant and Equipment Gross 286,968



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
125,104
214,687
268,557
653,626
884,010
1,080,985
1,423,720
2,182,135
2,243,898
3,102,763
2,484,109
2,740,346
3,140,778
3,501,431
3,147,803
2,926,774
3,054,985
2,890,880
2,890,8803,054,9852,926,7743,147,8033,501,4313,140,7782,740,3462,484,1093,102,7632,243,8982,182,1351,423,7201,080,985884,010653,626268,557214,687125,104
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
1,555,508
891,489
1,082,105
1,287,281
1,780,704
1,696,795
1,726,995
1,745,482
1,646,171
1,646,1711,745,4821,726,9951,696,7951,780,7041,287,2811,082,105891,4891,555,508000000000
       Cash And Cash Equivalents 
7,463
36,120
29,248
396,849
187,783
123,911
140,105
434,440
146,803
819,000
183,061
213,756
314,643
436,727
544,906
559,431
846,286
836,437
836,437846,286559,431544,906436,727314,643213,756183,061819,000146,803434,440140,105123,911187,783396,84929,24836,1207,463
       Short-term Investments 
0
1,400
1,233
1,268
1,335
0
0
1,100
0
0
0
0
0
0
0
0
0
0
00000000001,100001,3351,2681,2331,4000
       Net Receivables 
40,001
53,348
73,036
85,013
138,461
145,358
188,291
212,295
250,656
325,215
294,850
450,390
600,714
977,481
484,493
421,843
331,454
323,382
323,382331,454421,843484,493977,481600,714450,390294,850325,215250,656212,295188,291145,358138,46185,01373,03653,34840,001
       Inventory 
15,107
39,370
64,684
66,341
116,796
136,473
148,975
169,613
275,183
346,538
333,653
346,007
311,744
316,714
296,655
157,775
202,401
170,997
170,997202,401157,775296,655316,714311,744346,007333,653346,538275,183169,613148,975136,473116,79666,34164,68439,37015,107
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
1,592,620
1,658,241
1,853,497
1,720,727
1,451,008
1,199,779
1,309,503
1,244,709
1,244,7091,309,5031,199,7791,451,0081,720,7271,853,4971,658,2411,592,6200000000000
       Property Plant Equipment 
30,561
55,136
59,757
72,025
238,880
410,172
563,636
950,294
981,874
943,088
871,331
780,995
685,827
600,605
459,972
394,148
339,920
286,968
286,968339,920394,148459,972600,605685,827780,995871,331943,088981,874950,294563,636410,172238,88072,02559,75755,13630,561
       Goodwill 
0
0
0
0
0
0
0
0
150,523
150,523
150,523
131,505
131,505
87,698
38,857
32,943
32,943
32,943
32,94332,94332,94338,85787,698131,505131,505150,523150,523150,52300000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
58,598
118,991
309,377
502,582
0
0
0
0
0
00000502,582309,377118,99158,598000000000
       Intangible Assets 
10,645
15,020
22,926
2,855
2,267
8,819
14,294
23,264
297,218
148,484
355,880
362,263
386,479
319,352
233,359
174,852
240,150
211,996
211,996240,150174,852233,359319,352386,479362,263355,880148,484297,21823,26414,2948,8192,2672,85522,92615,02010,645
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
44,654
11,002
75,905
133,103
6,988
4,322
48,600
60,192
60,19248,6004,3226,988133,10375,90511,00244,6540000000000
> Total Liabilities 
60,715
106,777
130,769
128,547
322,419
420,813
713,213
1,056,427
1,226,954
1,412,887
809,853
1,017,454
1,416,737
1,847,700
1,916,188
714,647
870,021
768,714
768,714870,021714,6471,916,1881,847,7001,416,7371,017,454809,8531,412,8871,226,9541,056,427713,213420,813322,419128,547130,769106,77760,715
   > Total Current Liabilities 
60,715
106,777
130,769
128,547
303,588
403,129
688,464
948,500
1,052,258
1,207,434
618,562
832,714
1,214,422
1,732,342
1,701,380
666,803
701,140
562,272
562,272701,140666,8031,701,3801,732,3421,214,422832,714618,5621,207,4341,052,258948,500688,464403,129303,588128,547130,769106,77760,715
       Short-term Debt 
0
0
0
0
0
0
0
0
0
110,434
162,500
218,100
632,457
0
0
0
0
0
00000632,457218,100162,500110,434000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
110,434
162,500
218,100
632,457
957,373
894,489
130,000
121,500
113,500
113,500121,500130,000894,489957,373632,457218,100162,500110,434000000000
       Accounts payable 
22,326
53,001
56,718
44,933
86,395
69,376
105,764
171,707
277,573
239,492
131,380
133,411
171,231
93,668
69,394
34,261
49,630
37,902
37,90249,63034,26169,39493,668171,231133,411131,380239,492277,573171,707105,76469,37686,39544,93356,71853,00122,326
       Other Current Liabilities 
8,389
20,676
26,751
29,214
90,693
56,142
240,400
227,589
118,996
56,658
49,709
47,896
75,869
372,400
270,824
337,497
331,119
2,310
2,310331,119337,497270,824372,40075,86947,89649,70956,658118,996227,589240,40056,14290,69329,21426,75120,6768,389
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
191,291
184,740
202,315
115,358
214,808
47,844
168,881
206,441
206,441168,88147,844214,808115,358202,315184,740191,2910000000000
       Other Liabilities 
0
0
0
0
15,445
3,000
8,470
87,043
22,542
26,838
28,391
25,133
24,844
21,720
18,243
13,940
13,315
0
013,31513,94018,24321,72024,84425,13328,39126,83822,54287,0438,4703,00015,4450000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
197,852
204,726
206,880
228,795
125,310
81,749
62,526
63,374
0
063,37462,52681,749125,310228,795206,880204,726197,852000000000
> Total Stockholder Equity
64,253
107,647
137,789
525,079
559,798
624,388
659,800
1,098,165
994,078
1,640,386
1,626,443
1,691,510
1,699,543
1,555,994
1,171,321
2,156,345
2,124,446
2,080,652
2,080,6522,124,4462,156,3451,171,3211,555,9941,699,5431,691,5101,626,4431,640,386994,0781,098,165659,800624,388559,798525,079137,789107,64764,253
   Common Stock
25,490
68,500
68,500
91,500
91,500
183,000
183,000
201,794
201,794
225,623
812,241
812,241
812,241
812,241
812,241
1,055,911
1,055,911
0
01,055,9111,055,911812,241812,241812,241812,241812,241225,623201,794201,794183,000183,00091,50091,50068,50068,50025,490
   Retained Earnings 
29,396
8,858
35,836
69,971
100,352
158,717
189,754
228,488
244,928
245,361
229,780
244,729
302,120
98,505
-271,325
-358,523
-406,212
-468,930
-468,930-406,212-358,523-271,32598,505302,120244,729229,780245,361244,928228,488189,754158,717100,35269,97135,8368,85829,396
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
-3,689
0
51,317
4,708
0
0
0
0
0
000004,70851,3170-3,689000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue895,593
Cost of Revenue-274,678
Gross Profit620,914620,914
 
Operating Income (+$)
Gross Profit620,914
Operating Expense-940,736
Operating Income-45,143-319,821
 
Operating Expense (+$)
Research Development99,810
Selling General Administrative508,561
Selling And Marketing Expenses0
Operating Expense940,736608,372
 
Net Interest Income (+$)
Interest Income34,636
Interest Expense-12,471
Other Finance Cost-123
Net Interest Income22,042
 
Pretax Income (+$)
Operating Income-45,143
Net Interest Income22,042
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,594-45,143
EBIT - interestExpense = -12,471
-8,927
3,544
Interest Expense12,471
Earnings Before Interest and Taxes (EBIT)016,066
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax3,594
Tax Provision-13,612
Net Income From Continuing Ops-10,018-10,018
Net Income-8,927
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-22,042
 

Technical Analysis of Chongqing Lummy Pharmaceutical
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chongqing Lummy Pharmaceutical. The general trend of Chongqing Lummy Pharmaceutical is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chongqing Lummy Pharmaceutical's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chongqing Lummy Pharmaceutical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3 < 3 < 3.17.

The bearish price targets are: 2.45 > 2.03.

Tweet this
Chongqing Lummy Pharmaceutical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chongqing Lummy Pharmaceutical. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chongqing Lummy Pharmaceutical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chongqing Lummy Pharmaceutical. The current macd is -0.05075105.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chongqing Lummy Pharmaceutical price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chongqing Lummy Pharmaceutical. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chongqing Lummy Pharmaceutical price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Chongqing Lummy Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) ChartChongqing Lummy Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chongqing Lummy Pharmaceutical. The current adx is 27.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chongqing Lummy Pharmaceutical shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Chongqing Lummy Pharmaceutical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chongqing Lummy Pharmaceutical. The current sar is 2.5043525.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Chongqing Lummy Pharmaceutical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chongqing Lummy Pharmaceutical. The current rsi is 52.96. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Chongqing Lummy Pharmaceutical Daily Relative Strength Index (RSI) ChartChongqing Lummy Pharmaceutical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chongqing Lummy Pharmaceutical. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chongqing Lummy Pharmaceutical price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Chongqing Lummy Pharmaceutical Daily Stochastic Oscillator ChartChongqing Lummy Pharmaceutical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chongqing Lummy Pharmaceutical. The current cci is 16.03.

Chongqing Lummy Pharmaceutical Daily Commodity Channel Index (CCI) ChartChongqing Lummy Pharmaceutical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chongqing Lummy Pharmaceutical. The current cmo is 16.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Chongqing Lummy Pharmaceutical Daily Chande Momentum Oscillator (CMO) ChartChongqing Lummy Pharmaceutical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chongqing Lummy Pharmaceutical. The current willr is -27.41935484.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Chongqing Lummy Pharmaceutical is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Chongqing Lummy Pharmaceutical Daily Williams %R ChartChongqing Lummy Pharmaceutical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chongqing Lummy Pharmaceutical.

Chongqing Lummy Pharmaceutical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chongqing Lummy Pharmaceutical. The current atr is 0.12875411.

Chongqing Lummy Pharmaceutical Daily Average True Range (ATR) ChartChongqing Lummy Pharmaceutical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chongqing Lummy Pharmaceutical. The current obv is 248,012,064.

Chongqing Lummy Pharmaceutical Daily On-Balance Volume (OBV) ChartChongqing Lummy Pharmaceutical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chongqing Lummy Pharmaceutical. The current mfi is 55.44.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Chongqing Lummy Pharmaceutical Daily Money Flow Index (MFI) ChartChongqing Lummy Pharmaceutical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chongqing Lummy Pharmaceutical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Chongqing Lummy Pharmaceutical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chongqing Lummy Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.955
Ma 20Greater thanMa 502.848
Ma 50Greater thanMa 1002.868
Ma 100Greater thanMa 2003.204
OpenGreater thanClose2.870
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chongqing Lummy Pharmaceutical with someone you think should read this too:
  • Are you bullish or bearish on Chongqing Lummy Pharmaceutical? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chongqing Lummy Pharmaceutical? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chongqing Lummy Pharmaceutical

I send you an email if I find something interesting about Chongqing Lummy Pharmaceutical.


Comments

How you think about this?

Leave a comment

Stay informed about Chongqing Lummy Pharmaceutical.

Receive notifications about Chongqing Lummy Pharmaceutical in your mailbox!